OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimization of AAV vectors to target persistent viral reservoirs
Rossana Colón-Thillet, Keith R. Jerome, Daniel Stone
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Spatial Transcriptomics: Technical Aspects of Recent Developments and Their Applications in Neuroscience and Cancer Research
Han‐Eol Park, Song Hyun Jo, Rosalind H. Lee, et al.
Advanced Science (2023) Vol. 10, Iss. 16
Open Access | Times Cited: 39

Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside
Liang Xu, Shun Yao, Yifan Evan Ding, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6

Viral vectors: design and delivery for small RNA
Woon‐Puay Koh, Khatijah Yusoff, Adelene Ai Lian Song, et al.
Journal of Medical Microbiology (2025) Vol. 74, Iss. 2
Closed Access

Evaluation of Purification Methods for Minimizing Transgene Expression Background During Viral Manufacturing
Raphaela Bento, Alexandra Burr, Matthew Teryek, et al.
Human Gene Therapy (2025)
Closed Access

Strategies for Targeting Retroviral Integration for Safer Gene Therapy: Advances and Challenges
Kristine E. Yoder, Anthony J. Rabe, Richard Fishel, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 27

AAV-mediated gene therapy for sialidosis
Diantha van de Vlekkert, Huimin Hu, Jason A. Weesner, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2094-2112
Open Access | Times Cited: 4

T-cell specific in vivo gene delivery with DART-AAVs targeted to CD8
Muhammed Burak Demircan, Luca J. Zinser, Alexander Michels, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3470-3484
Open Access | Times Cited: 4

Inhibition of miR-25 ameliorates cardiac and skeletal muscle dysfunction in aged mdx/utrn haploinsufficient (+/−) mice
S. Kepreotis, Jae Gyun Oh, Mi Na Park, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102174-102174
Open Access | Times Cited: 3

Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions
Thomas Böldicke
Antibodies (2022) Vol. 11, Iss. 3, pp. 49-49
Open Access | Times Cited: 15

Adeno-associated virus vectors and neurotoxicity—lessons from preclinical and human studies
Daniel Stone, Martine Aubert, Keith R. Jerome
Gene Therapy (2023)
Open Access | Times Cited: 8

Targeting intracellular galectins for cancer treatment
Rita Nehmé, Yves St‐Pierre
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7

Machine-learning-guided Directed Evolution for AAV Capsid Engineering
Xianrong Fu, Hairui Suo, Jiachen Zhang, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 11, pp. 811-824
Closed Access | Times Cited: 2

AAV-mediated gene therapy for galactosialidosis: A long-term safety and efficacy study
Huimin Hu, Rosario Mosca, Elida Gomero, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 644-658
Open Access | Times Cited: 17

AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery
Sanna Koponen, Emmi Kokki, Toni Tamminen, et al.
Frontiers in Drug Delivery (2023) Vol. 3
Open Access | Times Cited: 6

Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary
Jill A. Morris, Chris Boshoff, Nina F. Schor, et al.
Molecular Therapy (2021) Vol. 29, Iss. 12, pp. 3332-3344
Open Access | Times Cited: 15

Current Advances in Adeno-Associated Virus-Mediated Gene Therapy to Prevent Acquired Hearing Loss
Fan Wu, Kumar Sambamurti, Su‐Hua Sha
Journal of the Association for Research in Otolaryngology (2022) Vol. 23, Iss. 5, pp. 569-578
Open Access | Times Cited: 9

Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, et al.
Biophysics Reviews (2023) Vol. 4, Iss. 1
Closed Access | Times Cited: 4

Development and evaluation of a mouse model susceptible to severe fever with thrombocytopenia syndrome virus by rAAV-based exogenous human DC-SIGN expression
Ji-Young Park, Chandran Sivasankar, Chamith Hewawaduge, et al.
Microbial Pathogenesis (2023) Vol. 178, pp. 106079-106079
Closed Access | Times Cited: 4

Liver-Humanized NSG-PiZ Mice Support the Study of Chronic Hepatitis B Virus Infection and Antiviral Therapies
Rossana Colón-Thillet, Daniel Stone, Michelle A. Loprieno, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 4

Mucopolysaccharidosis type IIIB: a current review and exploration of the AAV therapy landscape
Courtney J. Rouse, Victoria N. Jensen, Coy D. Heldermon
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 355-359
Open Access | Times Cited: 4

Multi-step engineered adeno-associated virus enables whole-brain mRNA delivery
Weiya Bai, Dong Yang, Yaqing Zhao, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1

Therapeutic Application and Structural Features of Adeno-Associated Virus Vector
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8464-8498
Open Access | Times Cited: 1

Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma
Seonhee Kim, Bo‐Kyoung Jung, Jinju Kim, et al.
Oncology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 1

Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects
Evgenii A. Lunev, Anna A. Karan, Tatiana V. Egorova, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1140-1140
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top